Application of Topical Recombinant Collagen After Fractional Radiofrequency Microneedling for Non-Invasive Facelift: A Case Study
-
By
-
Thien-Chong Marcus Wong
-
Yizhi Ong
-
June 29, 2026
Clinical Scorecard: Application of Topical Recombinant Collagen After Fractional Radiofrequency Microneedling for Non-Invasive Facelift: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | Fractional Radiofrequency Microneedling (FRM) |
| Key Mechanisms | Induces microinjury to stimulate neocollagenesis and elastin production. |
| Target Population | Adults with facial laxity, specifically females with Fitzpatrick skin type IV. |
| Care Setting | Clinical aesthetic procedures. |
Key Highlights
- Topical recombinant collagen applied post-FRM showed early reduction in erythema and edema.
- Patients reported immediate relief from discomfort after collagen application.
- No adverse events or side effects were reported in the case study.
Guideline-Based Recommendations
Diagnosis
- Assessment of facial laxity and skin type prior to FRM.
Management
- Application of topical recombinant collagen immediately post-FRM.
Monitoring & Follow-up
- Observe for erythema, edema, and patient-reported discomfort post-treatment.
Risks
- Common postprocedural effects include erythema, edema, bruising, and discomfort.
Patient & Prescribing Data
Two 40-year-old female patients with mild-to-moderate facial laxity.
Topical recombinant collagen may enhance recovery post-FRM.
Clinical Best Practices
- Document clinical photography before and after treatment for assessment.
- Consider patient-reported outcomes in post-treatment evaluations.
Related Resources & Content
